Sequential C-H Arylation And Enantioselective Hydrogenation Enables Ideal Asymmetric Entry To The Indenopiperidine Core Of An 11 Beta-Hsd-1 Inhibitor
Xudong Wei,Bo Qu,Xingzhong Zeng,Jolaine Savoie,Keith R Fandrick,Jean-Nicolas Desrosiers,Sergei Tcyrulnikov,Maurice A Marsini,Frederic G Buono,Zhibin Li,Bing-Shiou Yang,Wenjun Tang,Nizar Haddad,Osvaldo Gutierrez,Jun Wang,Heewon Lee,Shengli Ma,Scot Campbell,Jon C Lorenz,Matthias Eckhardt,Frank Himmelsbach,Stefan Peters,Nitinchandra D Patel,Zhulin Tan,Nathan K Yee,Jinhua J Song,Frank Roschangar,Marisa C Kozlowski,Chris H Senanayake
DOI: https://doi.org/10.1021/jacs.6b09764
IF: 15
2016-01-01
Journal of the American Chemical Society
Abstract:A concise asymmetric synthesis of an 11 beta-HSD-1 inhibitor has been achieved using inexpensive starting materials with excellent step-economy at low catalyst loadings. The catalytic enantioselective total synthesis of 1 was accomplished in 7 steps and 38% overall yield aided by the development of an innovative, sequential strategy involving Pd-catalyzed pyridinium C-H arylation and Ir-catalyzed asymmetric hydrogenation of the resulting fused tricyclic indenopyridinium salt highlighted by the use of a unique P,N-ligand (MeO-BoQPhos) with 1000 ppm of [Ir(COD)Cl](2).